{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:53Z","timestamp":1792788353682,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tanta University","id":[{"id":"https:\/\/ror.org\/016jp5b92","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03468-6","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T20:58:43Z","timestamp":1780693123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Parenteral to Oral Delivery: Facile Formulation of Oral Gemcitabine Nanospanlastics for Enhanced Bioavailability and Anticancer Activity in Murine Breast Cancer Model"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9021-7302","authenticated-orcid":false,"given":"Safaa E.","family":"Ramadan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5121-6771","authenticated-orcid":false,"given":"Suleiman S.","family":"Eltokhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9910-4333","authenticated-orcid":false,"given":"Sanaa A.","family":"El-Gizawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6203-1713","authenticated-orcid":false,"given":"Yusuf A.","family":"Haggag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"3468_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/IJN.S394819","volume":"18","author":"Y Zou","year":"2023","unstructured":"Zou Y, Gao W, Jin H, Mao C, Zhang Y, Wang X, et al. Cellular uptake and transport mechanism of 6-Mercaptopurine nanomedicines for enhanced oral bioavailability. Int J Nanomedicine. 2023;18:79\u201394. https:\/\/doi.org\/10.2147\/IJN.S394819.","journal-title":"Int J Nanomedicine"},{"key":"3468_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106766","volume":"107","author":"J L\u00f3pez-Seijas","year":"2025","unstructured":"L\u00f3pez-Seijas J, Iglesias-Fente A, Miranda-Balbuena D, Rey-Rico A. Exploiting niosomes as efficient non-viral vectors for enhanced gene transfer to human mesenchymal stem cells. J Drug Deliv Sci Technol. 2025;107:106766. https:\/\/doi.org\/10.1016\/j.jddst.2025.106766.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1-2","key":"3468_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijpharm.2011.04.027","volume":"413","author":"S Kakkar","year":"2011","unstructured":"Kakkar S, Kaur IP. Spanlastics-a novel nanovesicular carrier system for ocular delivery. Int J Pharm. 2011;413(1\u20132):202\u201310. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.04.027.","journal-title":"Int J Pharm"},{"issue":"5","key":"3468_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1089\/jop.2011.0176","volume":"28","author":"IP Kaur","year":"2012","unstructured":"Kaur IP, Rana C, Singh M, Bhushan S, Singh H, Kakkar S. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of Fluconazole. J Ocul Pharmacol Ther. 2012;28(5):484\u201396. https:\/\/doi.org\/10.1089\/jop.2011.0176.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"3468_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/08982104.2021.1918151","volume":"32","author":"AA Nemr","year":"2022","unstructured":"Nemr AA, El-Mahrouk GM, Badie HA. Development and evaluation of surfactant-based elastic vesicular system for transdermal delivery of Cilostazole: ex-vivo permeation and histopathological evaluation studies. J Liposome Res. 2022;32(2):159\u201371. https:\/\/doi.org\/10.1080\/08982104.2021.1918151.","journal-title":"J Liposome Res"},{"issue":"1-2","key":"3468_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijpharm.2017.03.005","volume":"522","author":"AM Al-Mahallawi","year":"2017","unstructured":"Al-Mahallawi AM, Khowessah OM, Shoukri RA. Enhanced non invasive trans-tympanic delivery of Ciprofloxacin through encapsulation into nano-Spanlastic vesicles: fabrication, in-vitro characterization, and comparative ex-vivo permeation studies. Int J Pharm. 2017;522(1\u20132):157\u201364. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.005.","journal-title":"Int J Pharm"},{"issue":"2","key":"3468_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1208\/s12249-016-0528-9","volume":"18","author":"NI Elsherif","year":"2017","unstructured":"Elsherif NI, Shamma RN, Abdelbary G. Terbinafine hydrochloride trans-ungual delivery via nanovesicular systems: in vitro characterization and ex vivo evaluation. AAPS PharmSciTech. 2017;18(2):551\u201362. https:\/\/doi.org\/10.1208\/s12249-016-0528-9.","journal-title":"AAPS PharmSciTech"},{"key":"3468_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104705","volume":"86","author":"H Fayez","year":"2023","unstructured":"Fayez H, Daihom B, El-Aleem YA, Ibrahim IT, Motaleb MA. Brain nanotargeted [131I] I-Rolapitant as a model for brain imaging: intranasal formulation, radiolabelling, biodistribution, and comparative study. J Drug Deliv Sci Technol. 2023;86:104705. https:\/\/doi.org\/10.1016\/j.jddst.2023.104705.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1-2","key":"3468_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijpharm.2015.02.012","volume":"483","author":"SA Tayel","year":"2015","unstructured":"Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicular spanlastic dispersions: Development, characterization and pharmacokinetic assessments. Int J Pharm. 2015;483(1\u20132):77\u201388. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.02.012.","journal-title":"Int J Pharm"},{"key":"3468_CR10","unstructured":"ACS: Key Statistics for Breast Cancer. https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/about\/how-common-is-breast-cancer.html (2025). Accessed 12 March 2025."},{"issue":"2","key":"3468_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3897\/folmed.66.e119570","volume":"66","author":"MRH Salem","year":"2024","unstructured":"Salem MRH, Chalabi N, Mohammed A, Yacoub GEE. The incidence of breast cancer in Egyptian females in correlation to different mammographic ACR densities. Folia Med (Plovdiv). 2024;66(2):213\u201320. https:\/\/doi.org\/10.3897\/folmed.66.e119570.","journal-title":"Folia Med (Plovdiv)"},{"issue":"Suppl 5","key":"3468_CR12","doi-asserted-by":"publisher","first-page":"v169","DOI":"10.1093\/annonc\/mdj975","volume":"17","author":"E Ferrazzi","year":"2006","unstructured":"Ferrazzi E, Stievano L. Gemcitabine: Monochemotherapy of breast cancer. Ann Oncol. 2006;17(Suppl 5):v169\u201372. https:\/\/doi.org\/10.1093\/annonc\/mdj975.","journal-title":"Ann Oncol"},{"key":"3468_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104505","volume":"84","author":"M Barani","year":"2023","unstructured":"Barani M, Hajinezhad MR, Zargari F, Shahraki S, Davodabadi F, Mirinejad S, et al. Preparation, characterization, cytotoxicity and pharmacokinetics of niosomes containing gemcitabine: In vitro, in vivo, and simulation studies. J Drug Deliv Sci Technol. 2023;84:104505. https:\/\/doi.org\/10.1016\/j.jddst.2023.104505.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"11","key":"3468_CR14","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1158\/1078-0432.CCR-07-4521","volume":"14","author":"SA Veltkamp","year":"2008","unstructured":"Veltkamp SA, Jansen RS, Callies S, Pluim D, Visseren-Grul CM, Rosing H, et al. Oral administration of gemcitabine in patients with refractory tumors: A clinical and pharmacologic study. Clin Cancer Res. 2008;14(11):3477\u201386. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4521.","journal-title":"Clin Cancer Res"},{"key":"3468_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bcp.2019.06.013","volume":"168","author":"BR Thompson","year":"2019","unstructured":"Thompson BR, Hu Y, Smith DE. Mechanisms of gemcitabine oral absorption as determined by in situ intestinal perfusions in mice. Biochem Pharmacol. 2019;168:57\u201364. https:\/\/doi.org\/10.1016\/j.bcp.2019.06.013.","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"3468_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-021-06623-6","volume":"32","author":"M Barani","year":"2021","unstructured":"Barani M, Hajinezhad MR, Sargazi S, Rahdar A, Shahraki S, Lohrasbi-Nejad A, et al. In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes. J Mater Sci Mater Med. 2021;32(12):147. https:\/\/doi.org\/10.1007\/s10856-021-06623-6.","journal-title":"J Mater Sci Mater Med"},{"key":"3468_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119632","volume":"278","author":"SH Shahcheraghi","year":"2021","unstructured":"Shahcheraghi SH, Aljabali AA, Al Zoubi MS, Mishra V, Charbe NB, Haggag YA, et al. Overview of key molecular and pharmacological targets for diabetes and associated diseases. Life Sci. 2021;278:119632. https:\/\/doi.org\/10.1016\/j.lfs.2021.119632.","journal-title":"Life Sci"},{"key":"3468_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123253","author":"EH Barakat","year":"2023","unstructured":"Barakat EH, Akl MA, Ibrahim MF, Mohamed Dawaba H, Afouna MI. Formulation and optimization of theophylline-loaded enteric-coated spanlastic nanovesicles for colon delivery; ameliorate acetic acid-induced ulcerative colitis. Int J Pharm. 2023. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123253.","journal-title":"Int J Pharm"},{"key":"3468_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102866","volume":"66","author":"ND Fayed","year":"2021","unstructured":"Fayed ND, Goda AE, Essa EA, El Maghraby GM. Chitosan-encapsulated niosomes for enhanced oral delivery of atorvastatin. J Drug Deliv Sci Technol. 2021;66:102866. https:\/\/doi.org\/10.1016\/j.jddst.2021.102866.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"3468_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/08982104.2017.1343835","volume":"28","author":"AA Sultan","year":"2018","unstructured":"Sultan AA, El-Gizawy SA, Osman MA, El Maghraby GM. Niosomes for oral delivery of nateglinide: in situ-in vivo correlation. J Liposome Res. 2018;28(3):209\u201317. https:\/\/doi.org\/10.1080\/08982104.2017.1343835.","journal-title":"J Liposome Res"},{"key":"3468_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2026.115003","volume":"221","author":"AA Elfarouny","year":"2026","unstructured":"Elfarouny AA, Haggag YA, Essa EA, El-Gizawy SA. Facile formulation of an oral nanovesicular carrier co-encapsulating simvastatin and ezetimibe for enhanced lipid-lowering effect. Eur J Pharm Biopharm. 2026;221:115003. https:\/\/doi.org\/10.1016\/j.ejpb.2026.115003.","journal-title":"Eur J Pharm Biopharm"},{"key":"3468_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105414","volume":"93","author":"NE Elkholy","year":"2024","unstructured":"Elkholy NE, Sultan AA, Abu-Risha SE, El Maghraby GM. Chitosan coated lipid carriers as nanoplatform for repurposed anti-breast cancer activity of niclosamide. J Drug Deliv Sci Technol. 2024;93:105414. https:\/\/doi.org\/10.1016\/j.jddst.2024.105414.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"3468_CR23","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02865-z","volume":"25","author":"MI Ghanem","year":"2024","unstructured":"Ghanem MI, Ashmawy SM, El Maghraby GM. Intestinal absorption site-guided development and evaluation of oral disintegrating controlled release tablets of mirabegron. AAPS PharmSciTech. 2024;25(6):167. https:\/\/doi.org\/10.1208\/s12249-024-02865-z.","journal-title":"AAPS PharmSciTech"},{"key":"3468_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115767","author":"NM El-Lakkany","year":"2021","unstructured":"El-Lakkany NM, Elkattan HH, Elsisi AE. The ponatinib\/gossypol novel combination provides enhanced anticancer activity against murine solid Ehrlich carcinoma via triggering apoptosis and inhibiting proliferation\/angiogenesis. Toxicol Appl Pharmacol. 2021. https:\/\/doi.org\/10.1016\/j.taap.2021.115767.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"3468_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/030089169307900408","volume":"79","author":"A-M Osman","year":"1993","unstructured":"Osman A-M, Ahmed MM, Khayyal MT, el-Merzabani MM. Hyperthermic potentiation of cisplatin cytotoxicity on solid Ehrlich carcinoma. Tumori. 1993;79(4):268\u201372. https:\/\/doi.org\/10.1177\/030089169307900408.","journal-title":"Tumori"},{"key":"3468_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115185","volume":"404","author":"AE Goda","year":"2020","unstructured":"Goda AE, Elsisi AE, Sokkar SS, Abdelrazik NM. Enhanced in vivo targeting of estrogen receptor alpha signaling in murine mammary adenocarcinoma by nilotinib\/rosuvastatin novel combination. Toxicol Appl Pharmacol. 2020;404:115185. https:\/\/doi.org\/10.1016\/j.taap.2020.115185.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"3468_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10717544.2021.1886377","volume":"28","author":"M Elhabak","year":"2021","unstructured":"Elhabak M, Ibrahim S, Abouelatta SM. Topical delivery of l-ascorbic acid spanlastics for stability enhancement and treatment of UVB induced damaged skin. Drug Deliv. 2021;28(1):445\u201353. https:\/\/doi.org\/10.1080\/10717544.2021.1886377.","journal-title":"Drug Deliv"},{"issue":"1","key":"3468_CR28","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1080\/10717544.2019.1686087","volume":"26","author":"SF El Menshawe","year":"2019","unstructured":"El Menshawe SF, Nafady MM, Aboud HM, Kharshoum RM, Elkelawy A, Hamad DS. Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund\u2019s adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway. Drug Deliv. 2019;26(1):1140\u201354. https:\/\/doi.org\/10.1080\/10717544.2019.1686087.","journal-title":"Drug Deliv"},{"issue":"1-2","key":"3468_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijpharm.2008.05.031","volume":"361","author":"M Mokhtar","year":"2008","unstructured":"Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;361(1\u20132):104\u201311. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.05.031.","journal-title":"Int J Pharm"},{"issue":"3","key":"3468_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1208\/s12249-008-9124-y","volume":"9","author":"Y Rao","year":"2008","unstructured":"Rao Y, Zheng F, Zhang X, Gao J, Liang W. In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers. AAPS PharmSciTech. 2008;9(3):860\u20135. https:\/\/doi.org\/10.1208\/s12249-008-9124-y.","journal-title":"AAPS PharmSciTech"},{"key":"3468_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121226","volume":"610","author":"K Sudhakar","year":"2021","unstructured":"Sudhakar K, Mishra V, Jain S, Rompicherla NC, Malviya N, Tambuwala MM. Development and evaluation of the effect of ethanol and surfactant in vesicular carriers on lamivudine permeation through the skin. Int J Pharm. 2021;610:121226. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121226.","journal-title":"Int J Pharm"},{"key":"3468_CR32","doi-asserted-by":"publisher","unstructured":"Ochubiojo M, Chinwude I, Ibanga E, Ifianyi S. Nanotechnology in Drug Delivery. In: Sezer AD, editor. Recent Advances in Novel Drug Carrier Systems. London, UK: InTech; 2012. p. 69\u2013106. https:\/\/doi.org\/10.5772\/51384.","DOI":"10.5772\/51384"},{"key":"3468_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00524","volume":"11","author":"S Hua","year":"2020","unstructured":"Hua S. Advances in oral drug delivery for regional targeting in the gastrointestinal tract - influence of physiological, pathophysiological and pharmaceutical factors. Front Pharmacol. 2020;11:524. https:\/\/doi.org\/10.3389\/fphar.2020.00524.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3468_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96199-6","volume":"11","author":"Y Bide","year":"2021","unstructured":"Bide Y, Fashapoyeh MA, Shokrollahzadeh S. Structural investigation and application of Tween 80-choline chloride self-assemblies as osmotic agent for water desalination. Sci Rep. 2021;11(1):17068. https:\/\/doi.org\/10.1038\/s41598-021-96199-6.","journal-title":"Sci Rep"},{"key":"3468_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122068","volume":"625","author":"SS Ibrahim","year":"2022","unstructured":"Ibrahim SS, Abd-Allah H. Spanlastic nanovesicles for enhanced ocular delivery of vanillic acid: in vitro characterization, and in vivo anti-inflammatory evaluation. Int J Pharm. 2022;625:122068. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122068.","journal-title":"Int J Pharm"},{"key":"3468_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3483511","volume":"2022","author":"NA Jusril","year":"2022","unstructured":"Jusril NA, Abu Bakar SI, Khalil KA, Md Saad WM, Wen NK, Adenan MI. Development and optimization of nanoemulsion from ethanolic extract of Centella asiatica (NanoSECA) using D-Optimal mixture design to improve blood-brain barrier permeability. Evid Based Complement Alternat Med. 2022;2022:3483511. https:\/\/doi.org\/10.1155\/2022\/3483511.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1-2","key":"3468_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.07.050","volume":"530","author":"FE Abdelrahman","year":"2017","unstructured":"Abdelrahman FE, Elsayed I, Gad MK, Elshafeey AH, Mohamed MI. Response surface optimization, ex vivo and in vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone. Int J Pharm. 2017;530(1\u20132):1\u201311. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.07.050.","journal-title":"Int J Pharm"},{"key":"3468_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118556","volume":"568","author":"E Elmowafy","year":"2019","unstructured":"Elmowafy E, El-Gogary RI, Ragai MH, Nasr M. Novel antipsoriatic fluidized spanlastic nanovesicles: in vitro physicochemical characterization, ex vivo cutaneous retention and exploratory clinical therapeutic efficacy. Int J Pharm. 2019;568:118556. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118556.","journal-title":"Int J Pharm"},{"key":"3468_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.103061","volume":"68","author":"CE Mary Dcruz","year":"2022","unstructured":"Mary Dcruz CE, Bhide PJ, Kumar L, Shirodkar RK. Novel nano spanlastic carrier system for buccal delivery of lacidipine. J Drug Deliv Sci Technol. 2022;68:103061. https:\/\/doi.org\/10.1016\/j.jddst.2021.103061.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"3468_CR40","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s13346-020-00814-4","volume":"11","author":"NM Sallam","year":"2021","unstructured":"Sallam NM, Sanad RAB, Ahmed MM, Khafagy ELS, Ghorab M, Gad S. Impact of the mucoadhesive lyophilized wafer loaded with novel carvedilol nano-spanlastics on biochemical markers in the heart of spontaneously hypertensive rat models. Drug Deliv Transl Res. 2021;11(3):1009\u201336. https:\/\/doi.org\/10.1007\/s13346-020-00814-4.","journal-title":"Drug Deliv Transl Res"},{"issue":"1-2","key":"3468_CR41","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ijpharm.2010.06.034","volume":"397","author":"GM El Zaafarany","year":"2010","unstructured":"El Zaafarany GM, Awad GA, Holayel SM, Mortada ND. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 2010;397(1\u20132):164\u201372. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.06.034.","journal-title":"Int J Pharm"},{"issue":"3-4","key":"3468_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/10717544.2013.779332","volume":"20","author":"AA Hasan","year":"2013","unstructured":"Hasan AA, Madkor H, Wageh S. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Deliv. 2013;20(3\u20134):120\u20136. https:\/\/doi.org\/10.3109\/10717544.2013.779332.","journal-title":"Drug Deliv"},{"issue":"9","key":"3468_CR43","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1016\/j.actbio.2012.05.022","volume":"8","author":"Y Jin","year":"2012","unstructured":"Jin Y, Yue X, Zhang Q, Wu X, Cao Z, Dai Z. Cerasomal doxorubicin with long-term storage stability and controllable sustained release. Acta Biomater. 2012;8(9):3372\u201380. https:\/\/doi.org\/10.1016\/j.actbio.2012.05.022.","journal-title":"Acta Biomater"},{"issue":"2","key":"3468_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020641","volume":"15","author":"I Gupta","year":"2023","unstructured":"Gupta I, Adin SN, Rashid MA, Alhamhoom Y, Aqil M, Mujeeb M. Spanlastics as a potential approach for enhancing the nose-to-brain delivery of Piperine: in vitro prospect and in vivo therapeutic efficacy for the management of epilepsy. Pharmaceutics. 2023;15(2):641. https:\/\/doi.org\/10.3390\/pharmaceutics15020641.","journal-title":"Pharmaceutics"},{"issue":"4","key":"3468_CR45","doi-asserted-by":"publisher","first-page":"884","DOI":"10.29228\/jrp.187","volume":"26","author":"S Priyanka","year":"2022","unstructured":"Priyanka S, Nithya R. Lisinopril dihydrate loaded nano-spanlastic bio-adhesive gel for intranasal delivery: 23 factorial optimization, fabrication and ex-vivo studies for enhanced mucosal permeation. J Res Pharm. 2022;26(4):884\u201399. https:\/\/doi.org\/10.29228\/jrp.187.","journal-title":"J Res Pharm"},{"key":"3468_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115243","volume":"226","author":"B Henry","year":"2023","unstructured":"Henry B, Samokhvalov A. Characterization of tautomeric forms of anti-cancer drug gemcitabine and their interconversion upon mechano-chemical treatment, using ATR-FTIR spectroscopy and complementary methods. J Pharm Biomed Anal. 2023;226:115243. https:\/\/doi.org\/10.1016\/j.jpba.2023.115243.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"3468_CR47","doi-asserted-by":"publisher","DOI":"10.1088\/2057-1976\/ab73f7","volume":"6","author":"P Kush","year":"2020","unstructured":"Kush P, Kaur M, Sharma M, Madan J, Kumar P, Deep A, et al. Investigations of potent biocompatible metal-organic framework for efficient encapsulation and delivery of Gemcitabine: biodistribution, pharmacokinetic and cytotoxicity study. Biomed Phys Eng Express. 2020;6(2):025014. https:\/\/doi.org\/10.1088\/2057-1976\/ab73f7.","journal-title":"Biomed Phys Eng Express"},{"issue":"1","key":"3468_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3906\/kim-1801-68","volume":"43","author":"G A\u00c7Ik","year":"2019","unstructured":"A\u00c7Ik G, Kamaci M, \u00d6Zata B, \u00d6Zen Cansoy CE. Effect of polyvinyl alcohol\/chitosan blend ratios on morphological, optical, andthermal properties of electrospun nanofibers. Turk J Chem. 2019;43(1):137\u201349. https:\/\/doi.org\/10.3906\/kim-1801-68.","journal-title":"Turk J Chem"},{"key":"3468_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2023.100201","author":"OA Agha","year":"2023","unstructured":"Agha OA, Girgis GNS, El-Sokkary MMA, Soliman OAE. Spanlastic-laden in situ gel as a promising approach for ocular delivery of Levofloxacin: in-vitro characterization, microbiological assessment, corneal permeability and in-vivo study. Int J Pharm X. 2023. https:\/\/doi.org\/10.1016\/j.ijpx.2023.100201.","journal-title":"Int J Pharm X"},{"issue":"3","key":"3468_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/10667857.2020.1734729","volume":"36","author":"VV Pande","year":"2020","unstructured":"Pande VV, Khedkar PV, Giri MA, Pote AK, Polshettiwar SA. Fabrication and characterisation of gemcitabine hydrochloride loaded magnetically responsive mesoporous silica nanocomposites as smart hybrid theranostic platform for treatment of pancreatic cancer. Mater Technol. 2020;36(3):145\u201352. https:\/\/doi.org\/10.1080\/10667857.2020.1734729.","journal-title":"Mater Technol"},{"issue":"4","key":"3468_CR51","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1007\/s10854-019-02835-3","volume":"31","author":"SS Devangamath","year":"2020","unstructured":"Devangamath SS, Lobo B, Masti SP, Narasagoudr S. Thermal, mechanical, and AC electrical studies of PVA\u2013PEG\u2013Ag2S polymer hybrid material. J Mater Sci Mater Electron. 2020;31(4):2904\u201317. https:\/\/doi.org\/10.1007\/s10854-019-02835-3.","journal-title":"J Mater Sci Mater Electron"},{"issue":"4","key":"3468_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-024-09850-w","volume":"19","author":"GE Yassin","year":"2024","unstructured":"Yassin GE, Amer MA, Mannaa IM, Khalifa MKA. Fluconazole-niosome-laden contact lens: a promising therapeutic approach for prolonged ocular delivery and enhanced antifungal activity. J Pharm Innov. 2024;19(4):45. https:\/\/doi.org\/10.1007\/s12247-024-09850-w.","journal-title":"J Pharm Innov"},{"issue":"1","key":"3468_CR53","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.colsurfb.2009.07.015","volume":"74","author":"S Gupta","year":"2009","unstructured":"Gupta S, Pramanik AK, Kailath A, Mishra T, Guha A, Nayar S, et al. Composition dependent structural modulations in transparent poly (vinyl alcohol) hydrogels. Colloids Surf B Biointerfaces. 2009;74(1):186\u201390. https:\/\/doi.org\/10.1016\/j.colsurfb.2009.07.015.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"33","key":"3468_CR54","doi-asserted-by":"publisher","first-page":"8569","DOI":"10.1016\/j.biomaterials.2012.07.063","volume":"33","author":"C He","year":"2012","unstructured":"He C, Yin L, Tang C, Yin C. Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs. Biomaterials. 2012;33(33):8569\u201378. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.07.063.","journal-title":"Biomaterials"},{"key":"3468_CR55","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.colsurfb.2016.10.028","volume":"149","author":"AA Sultan","year":"2017","unstructured":"Sultan AA, El-Gizawy SA, Osman MA, El Maghraby GM. Self dispersing mixed micelles forming systems for enhanced dissolution and intestinal permeability of hydrochlorothiazide. Colloids Surf B Biointerfaces. 2017;149:206\u201316. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.10.028.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3468_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122427","volume":"630","author":"AA Sultan","year":"2023","unstructured":"Sultan AA, Saad GA, El Maghraby GM. Permeation enhancers loaded bilosomes for improved intestinal absorption and cytotoxic activity of doxorubicin. Int J Pharm. 2023;630:122427. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122427.","journal-title":"Int J Pharm"},{"issue":"1","key":"3468_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/jps.2600660117","volume":"66","author":"T Maeda","year":"1977","unstructured":"Maeda T, Takenaka H, Yamahira Y, Noguchi T. Use of rabbits for GI drug absorption studies. J Pharm Sci. 1977;66(1):69\u201373. https:\/\/doi.org\/10.1002\/jps.2600660117.","journal-title":"J Pharm Sci"},{"key":"3468_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2021.127246","volume":"627","author":"S Rathod","year":"2021","unstructured":"Rathod S, Arya S, Shukla R, Ray D, Aswal VK, Bahadur P, et al. Investigations on the role of edge activator upon structural transitions in Span vesicles. Colloids Surf Physicochem Eng Aspects. 2021;627:127246. https:\/\/doi.org\/10.1016\/j.colsurfa.2021.127246.","journal-title":"Colloids Surf Physicochem Eng Aspects"},{"key":"3468_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2024.114321","volume":"245","author":"T Song","year":"2025","unstructured":"Song T, Yuan L, Wang J, Li W, Sun Y. Advances in the transport of oral nanoparticles in gastrointestinal tract. Colloids Surf B Biointerfaces. 2025;245:114321. https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114321.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"3468_CR60","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1306-2","volume":"20","author":"AM Fahmy","year":"2019","unstructured":"Fahmy AM, El-Setouhy DA, Habib BA, Tayel SA. Enhancement of transdermal delivery of Haloperidol via Spanlastic dispersions: entrapment efficiency vs. particle size. AAPS PharmSciTech. 2019;20(3):95. https:\/\/doi.org\/10.1208\/s12249-019-1306-2.","journal-title":"AAPS PharmSciTech"},{"key":"3468_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00713","volume":"10","author":"OY Mady","year":"2019","unstructured":"Mady OY, Donia AA, Al-Shoubki AA, Qasim W. Paracellular pathway enhancement of metformin hydrochloride via molecular dispersion in span 60 microparticles. Front Pharmacol. 2019;10:713. https:\/\/doi.org\/10.3389\/fphar.2019.00713.","journal-title":"Front Pharmacol"},{"issue":"10","key":"3468_CR62","doi-asserted-by":"publisher","first-page":"15627","DOI":"10.1021\/acsnano.2c05317","volume":"16","author":"J Wu","year":"2022","unstructured":"Wu J, Zhu Z, Liu W, Zhang Y, Kang Y, Liu J, et al. How nanoparticles open the paracellular route of biological barriers: mechanisms, applications, and prospects. ACS Nano. 2022;16(10):15627\u201352. https:\/\/doi.org\/10.1021\/acsnano.2c05317.","journal-title":"ACS Nano"},{"key":"3468_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114127","volume":"180","author":"BR Thompson","year":"2020","unstructured":"Thompson BR, Shi J, Zhu HJ, Smith DE. Pharmacokinetics of gemcitabine and its amino acid ester prodrug following intravenous and oral administrations in mice. Biochem Pharmacol. 2020;180:e114127. https:\/\/doi.org\/10.1016\/j.bcp.2020.114127.","journal-title":"Biochem Pharmacol"},{"key":"3468_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120532","volume":"600","author":"YA Haggag","year":"2021","unstructured":"Haggag YA, Yasser M, Tambuwala MM, El Tokhy SS, Isreb M, Donia AA. Repurposing of Guanabenz acetate by encapsulation into long-circulating nanopolymersomes for treatment of triple-negative breast cancer. Int J Pharm. 2021;600:120532. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120532.","journal-title":"Int J Pharm"},{"issue":"36","key":"3468_CR65","doi-asserted-by":"publisher","first-page":"26524","DOI":"10.1039\/d4ra03542a","volume":"14","author":"C Lamie","year":"2024","unstructured":"Lamie C, Elmowafy E, Attia D, Mortada ND. Glucospanlastics: innovative antioxidant and anticancer ascorbyl-2-glucoside vesicles for striking topical performance of repurposed itraconazole. RSC Adv. 2024;14(36):26524\u201343. https:\/\/doi.org\/10.1039\/d4ra03542a.","journal-title":"RSC Adv"},{"issue":"1","key":"3468_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05461-3","volume":"7","author":"M Azizi","year":"2017","unstructured":"Azizi M, Ghourchian H, Yazdian F, Bagherifam S, Bekhradnia S, Nystr\u00f6m B. Anti-cancerous effect of albumin coated silver nanoparticles on MDA-MB 231 human breast cancer cell line. Sci Rep. 2017;7(1):e5178. https:\/\/doi.org\/10.1038\/s41598-017-05461-3.","journal-title":"Sci Rep"},{"key":"3468_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106663","volume":"105","author":"IA Justino","year":"2025","unstructured":"Justino IA, Ferreira IR, Botteon CA, Tucci LFF, Marincek A, Amaral R, et al. Cytotoxic potential of polymeric nanoparticles loaded with Brazilian red propolis in breast cancer. J Drug Deliv Sci Technol. 2025;105:e106663. https:\/\/doi.org\/10.1016\/j.jddst.2025.106663.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3468_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-023-04096-4","volume":"23","author":"S Elnawasany","year":"2023","unstructured":"Elnawasany S, Haggag YA, Shalaby SM, Soliman NA, El Saadany AA, Ibrahim MA, et al. Anti-cancer effect of nano-encapsulated boswellic acids, curcumin and naringenin against HepG-2 cell line. BMC Complement Med Ther. 2023;23(1):270.","journal-title":"BMC Complement Med Ther"},{"key":"3468_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.nut.2018.06.018","volume":"58","author":"NK Badr El-Din","year":"2019","unstructured":"Badr El-Din NK, Ali DA, Abou-El-Magd RF. Grape seeds and skin induce tumor growth inhibition via G1-phase arrest and apoptosis in mice inoculated with Ehrlich ascites carcinoma. Nutrition. 2019;58:100\u20139. https:\/\/doi.org\/10.1016\/j.nut.2018.06.018.","journal-title":"Nutrition"},{"key":"3468_CR70","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8812983","volume":"2020","author":"I Mascherona","year":"2020","unstructured":"Mascherona I, Maggioli C, Biggiogero M, Mora O, Marelli L. A severe case of drug-induced liver injury after gemcitabine administration: A highly probable causality grading as assessed by the updated RUCAM diagnostic scoring system. Case Rep Hepatol. 2020;2020:e8812983. https:\/\/doi.org\/10.1155\/2020\/8812983.","journal-title":"Case Rep Hepatol"},{"key":"3468_CR71","unstructured":"Tanaka H, Takamori H, Eto S, Ozaki N, Akaboshi S, Nakahara O, et al. Acute liver injury with hepatic encephalopathy associated with gemcitabine administration for adjuvant chemotherapy in an HBV carrier with pancreatic cancer. Gan To Kagaku Ryoho. 2010;37(9):1783\u20136. https:\/\/pubmed.ncbi.nlm.nih.gov\/20841947\/."},{"issue":"5","key":"3468_CR72","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1021\/acs.molpharmaceut.6b00929","volume":"14","author":"K Kattel","year":"2017","unstructured":"Kattel K, Mondal G, Lin F, Kumar V, Mahato RI. Biodistribution of self-assembling polymer-gemcitabine conjugate after systemic administration into orthotopic pancreatic tumor bearing mice. Mol Pharm. 2017;14(5):1365\u201372. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00929.","journal-title":"Mol Pharm"},{"issue":"2","key":"3468_CR73","first-page":"106","volume":"25","author":"S Boussios","year":"2012","unstructured":"Boussios S, Pentheroudakis G, Katsanos K, Pavlidis N. Systemic treatment-induced gastrointestinal toxicity: Incidence, clinical presentation and management. Ann Gastroenterol. 2012;25(2):106\u201318.","journal-title":"Ann Gastroenterol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03468-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03468-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03468-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:03:53Z","timestamp":1790276633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03468-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":73,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["3468"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03468-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The rabbits and mice utilized in this study were processed in harmony with approved laboratory techniques established on the protocol that was permitted by Tanta University's faculty of pharmacy's ethical committee (approval number: TP\/RE\/3\/25 p-02).","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest was reported by the authors.","order":2,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"227"}}